The Interprofessional Medication Assessment for Older Patients
1 other identifier
interventional
514
1 country
5
Brief Summary
The objective of this pragmatic multi-center randomized controlled trial is to test the effectiveness of interprofessional medication assessment in older patients needing home care due to their diseases or decreased functional capacity in primary care. The main hypothesis is that intervention has a positive impact on functional capacity and for rational and safe use of medicines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2015
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 13, 2015
CompletedFirst Posted
Study publicly available on registry
March 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJune 13, 2016
June 1, 2016
1.3 years
March 13, 2015
June 10, 2016
Conditions
Outcome Measures
Primary Outcomes (5)
Functional capacity IADL (Instrumental Activities of Daily Living)
at 6 months from baseline
Functional capacity ADL (Activities of daily living;KATZ)
at 6 months from baseline
Functional capacity TUG (Timed up and go)
at 6 months from baseline
Functional capacity MMSE ( Mini-mental state examination)
at 6 months from baseline
Functional capacity GDS (Geriatric Depression Scale)-15
at 6 months from baseline
Secondary Outcomes (6)
Use of health care services
at 6 and 12 months from baseline
Need of services delivered to home
at 6 and 12 months from baseline
Number of medicines
at 6 and 12 months from baseline
Quality of medicines
at 6 and 12 months from baseline
Cost of medicines
at 6 and 12 months from baseline
- +1 more secondary outcomes
Study Arms (2)
Active comparator
ACTIVE COMPARATORIn addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
Usual care
NO INTERVENTIONUsual care (reference group).
Interventions
Intervention * Phase I: A medication assessment conducted by an interprofessional team including nurse, pharmacist and physician. The assessment is based on current medication list and basic information cathered by nurse. * Phase II: This phase is needed if the assessment cannot be conducted safely without physical examination conducted by physician. The comprehensive interprofessional assessment takes place after the clinical examination conducted by home care physician.
Eligibility Criteria
You may qualify if:
- Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
You may not qualify if:
- Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- East Savo Hospital Districtlead
- University of Eastern Finlandcollaborator
- Finnish Medicines Agencycollaborator
Study Sites (5)
Welfare district of Forssa
Forssa, FI 30100, Finland
Selänne Basic Health Care District
Haapajärvi, FI 85800, Finland
Juva Health Care
Juva, FI-51900, Finland
City of Lahti, home care
Lahti, FI-15100, Finland
Eastern Savo Hospital District
Savonlinna, FI-57100, Finland
Related Publications (1)
Auvinen K, Voutilainen A, Jyrkka J, Lonnroos E, Mantyselka P. Interprofessional medication assessment among home care patients: any impact on functioning? Results from a randomised controlled trial. BMC Geriatr. 2020 Oct 6;20(1):390. doi: 10.1186/s12877-020-01796-1.
PMID: 33023497DERIVED
Study Officials
- STUDY CHAIR
Pekka Mäntyselkä, MD
Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2015
First Posted
March 26, 2015
Study Start
February 1, 2015
Primary Completion
June 1, 2016
Study Completion
December 1, 2018
Last Updated
June 13, 2016
Record last verified: 2016-06